Stock Fundamentals

Company Information

Company Name
Scynexis Inc
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: US8112922005
CIK: 0001178253
CUSIP: 811292101
Currency: USD
Full Time Employees: 18
Phone: 201 884 5485
Fiscal Year End: December
IPO Date: May 02, 2014
Description:

SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.

Address:

1 Evertrust Plaza, Jersey City, NJ, United States, 07302-6548

Directors & Officers

Name Title Year Born
Dr. David Gonzalez Angulo M.D. CEO, President & Director 1965
Mr. Ivor Macleod CPA, M.B.A. Chief Financial Officer 1961
Mr. Scott Sukenick J.D. Chief Legal Officer & Corporate Secretary 1978
Ms. Daniella Gigante Vice President of Human Resources & Information Technology NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 12, 2024 Gonzalez David Angulo N/A Purchase 20.00K $1.37 $27.40K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Squadron Capital Management LLC 7.61M Mar 31, 2026 9.58% $2.56 0.00%
Great Point Partners LLC 7.55M Mar 31, 2026 9.51% $1.59 0.00%
Avidity Partners Management LP 4.16M Mar 31, 2026 5.24% $0.41 100.00%
Heights Capital Management Inc 2.09M Mar 31, 2026 2.63% $0.53 0.00%
Kingdon Capital Management LLC 1.98M Mar 31, 2026 2.50% $0.20 0.00%
Empery Asset Management, LP 1.85M Mar 31, 2026 2.33% $2.04 0.00%
Vanguard Group Inc 1.76M Dec 31, 2025 2.22% $0.00 0.00%
Dafna Capital Management LLC 1.09M Mar 31, 2026 1.37% $0.23 0.00%
Acadian Asset Management LLC 731.95K Mar 31, 2026 0.92% $0.00 0.00%
Millennium Management LLC 622.16K Mar 31, 2026 0.78% $0.00 0.00%
Geode Capital Management, LLC 486.37K Mar 31, 2026 0.61% $0.00 8.27%
BlackRock Inc 332.19K Mar 31, 2026 0.42% $0.00 -0.73%
Renaissance Technologies Corp 224.64K Mar 31, 2026 0.28% $0.00 27.64%
Yakira Capital Management, Inc. 188.60K Mar 31, 2026 0.24% $0.05 -0.63%
Citadel Advisors Llc 130.83K Mar 31, 2026 0.16% $0.00 25.88%
Bridgeway Capital Management, LLC 124.44K Mar 31, 2026 0.16% $0.00 -24.09%
Empowered Funds, LLC 123.70K Mar 31, 2026 0.16% $0.00 0.00%
State Street Corp 120.73K Mar 31, 2026 0.15% $0.00 0.00%
Northern Trust Corp 95.58K Mar 31, 2026 0.12% $0.00 26.67%
GSA Capital Partners LLP 87.54K Mar 31, 2026 0.11% $0.01 -45.62%

Shares Statistics

Shares Outstanding: 9.93M
Shares Float: 7.70M
% Insiders: 209.80%
% Institutions: 4,232.70%
Short % Float: 2.92%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 1.14M 0.23% ▲ 0.00% Apr 30, 2026
2 Vanguard Institutional Extnd Mkt Idx Tr 491.47K 0.10% ▲ 17.01% Apr 30, 2026
3 Vifag 2002 SICAV 350.00K 0.07% ▲ 0.00% Feb 28, 2026
4 Fidelity Extended Market Index 253.91K 0.05% ▲ 13.45% Mar 31, 2026
5 EA Bridgeway Omni Small-Cap Value ETF 123.70K 0.02% ▲ 0.00% Apr 30, 2026
6 Extended Equity Market Fund B 80.95K 0.02% ▲ 0.00% Dec 31, 2025
7 Blackrock Extended Mkt Fund CF 80.95K 0.02% ▲ 0.00% Apr 30, 2026
8 Extended Equity Market Fund E 80.95K 0.02% ▲ 0.00% Dec 31, 2025
9 BlackRock Extended Equity Market Fund K 68.93K 0.01% ▼ 0.73% Mar 31, 2026
10 Fidelity Total Market Index 66.66K 0.01% ▲ 0.00% Mar 31, 2026

Valuation Metrics

Enterprise Value: $-4.27M
Trailing P/E: 0.00
Forward P/E: 3.72

Financial Highlights

Market Cap: $46.37M
EBITDA: $-36.54M
PEG Ratio: $0.00
Book Value: $0.67
Earnings/Share: $-3.84
Profit Margin: -120.51%
Operating Margin: -119.95%
ROA (TTM): -20.96%
ROE (TTM): -53.39%
Revenue (TTM): $20.34M
Revenue/Share (TTM): $3.24
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 1,808.50%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 7.04x 0.01x 0.16x -92.91x -0.06x
2024-12-31 3.00x 0.26x 0.39x -14.53x -0.76x
2023-12-31 6.26x 0.17x 0.43x 11.87x 0.18x
2022-12-31 4.49x 14.13x 0.96x -12.64x -0.76x
2021-12-31 8.03x 0.70x 0.66x -15.35x -0.88x
2020-12-31 3.72x 0.73x 0.78x -43.31x -0.30x
2019-12-31 4.76x 0.90x 0.77x -22.68x -0.23x
2018-12-31 8.76x 0.48x 0.41x -14.60x -0.88x
2017-12-31 4.43x 0.68x 0.53x -14.19x -0.63x
2016-12-31 15.96x 0.82x 0.42x -61.68x -0.97x
2015-12-31 7.27x 0.00x 0.15x -2,577.18x 0.00x
2014-12-31 7.41x 0.07x 0.16x -18.24x -1.02x
2013-12-31 0.16x -1.72x 1.70x -0.61x -1.09x
2012-12-31 0.37x -1.37x 2.60x -8.01x -2.72x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about SCYX.US!